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Abstract
Reports suggest children with high aerobic fitness (VO2max; mL/kg/min) have healthier profiles of
TNF-α and IL-6; however, research has not accounted for differences in adiposity between high-
fit and low-fit individuals. Thus, this study examined differences in inflammatory markers of
obese and normal weight children of different fitness levels, using two different VO2max units: per
unit of fat free mass (VO2FFM) or total body mass (VO2kg). Children (n = 124; ages 8–12) were
divided into four matched groups; normal weight high-fit (NH), normal weight low-fit (NL), obese
high-fit (OH), and obese low-fit (OL). Height, weight, skinfolds, body mass index (BMI), and
predicted VO2max were measured and a morning, fasting blood sample taken. IL-6 was elevated in
the NL and OL groups compared with the NH group, as well as the OL group compared with the
OH group. No differences were found in TNF-α. The relationship between IL-6 or TNF-α and the
two units of predicted VO2max did not differ suggesting that either VO2FFM or VO2kg can be
used to describe aerobic power when studying inflammation and exercise in youth. The
relationship between IL-6 or TNF-α and predicted VO2max, whether expressed per mass or per fat-
free mass was similar, suggesting that both can be used to describe aerobic power when studying
inflammation and exercise in youth. Given the polar design of this study, this relationship should
be confirmed including overweight subjects.
Adipose tissue is one of the main sites of production of tumor necrosis factor-α (TNF-α) and
interleukin-6 (IL-6) and circulating levels of these cytokines are directly related to the
amount of adipose tissue (3,6,7,10,11,13,14). From a health perspective, elevated circulating
TNF-α and IL-6 have been proposed as markers of inflammation used to link obesity with
insulin resistance and diabetes, as well as atherosclerosis (7,13). Thus, obesity has been
characterized as a low-grade inflammatory state (7).
In contrast to obesity, increased cardiorespiratory or aerobic fitness (VO2max) has been
associated with reduced levels of cytokines in adults (2) and, in some way, may positively
influence the relationship between obesity and cytokines. However, very little research has
explored this interrelationship in children. Although studies of children have examined the
associations between fitness, fatness, obesity, and cytokines, only one study was found that
examined the relationship of obesity and inflammation in high-fit and low-fit adolescents
(11). Results of that study suggest that TNF-α level is primarily determined by fitness level
and the elevated levels of IL-6 associated with obesity is reduced if the obesity is
accompanied by an elevated level of aerobic fitness. Thus, obese children with an increased
level of aerobic fitness may have reduced TNF-α and IL-6 levels (11). However, the author's
definition of fitness (>5 MET max capacity) and obesity (BMI> 22.5 kg/m 2) does not
represent the typical range of fitness or obesity for children, thus, the need for further
research in this area.
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When examining the associations between obesity related inflammation and aerobic fitness
one issue of concern is the unit used to express aerobic fitness. The most common metric
used is oxygen uptake relative to total body mass (VO2max; ml/kg/min). However, using a
metric that includes total body mass may be problematic because body mass includes both
lean and fat mass and, as previously mentioned, fat mass is associated with elevated
cytokines. Using a metric that includes only fat free mass, such as oxygen uptake per
kilogram fat free mass per minute (VO2FFM) may remove the confounding issue of fat mass
and theoretically present a more accurate depiction of the relationship between inflammation
and aerobic fitness. Therefore the purpose of this study is to explore a metric for fitness that
removes the impact of increased levels of adipose tissue to determine which unit is most
appropriate when including obese and normal weight children. In addition, we attempt to
determine if differences in TNF-α and IL-6 exist between adolescents who are obese or of
normal weight and possess high and low aerobic fitness.
Methods
Subjects
A total of 124 children were selected from 1486 participants in Cohort five of the
Cardiovascular Health in Children III study, based on their body mass and fitness status. The
CHIC III study was an investigation of youth from rural areas exploring risk factors for
cardiovascular disease and the metabolic syndrome. Of the original 1486 participants, the
sex and race distribution was ~50% male, 50% female, 55% African American, 37%
Caucasian, and 8% other races, with a mean age was 9.7 ± 1.1 years old. The subsample
used for the present investigation included subjects aged 10.0 ± 0.9 (52 female, 72 male, 72
African American, 39 Caucasian, and 13 other races). Subjects were chosen and matched in
4 groups based upon their weight and their predicted aerobic fitness (pVO2max) status:
obese high-fit (OH), obese low-fit (OL), normal weight high-fit (NH), and normal weight
low-fit (NL). Only youth in Tanner stages 1–3 were included in the study. All subjects gave
written assent and their parents provided consent before participation, by signing the
institutional IRB approved forms.
Data Collection Procedures
All anthropometric and exercise testing was completed in the subject's school during the
school day. Blood was drawn early in the morning, also at the school site. Height was
measured using a standard stadiometer (Perspective Enterprises, Portage, MI). Body mass
was determined using a calibrated electronic scale (Model 2101L, Healthometer Medical,
Bridgewater. IL). Body mass index (BMI) was calculated: [mass (kg)/height (m)2]. Pubertal
status was estimated using the Pubertal Development Scale (19), a sex-specific self-
administered questionnaire with 5-item subscales. Skinfolds were measured in triplicate
using calibrated Lange Skinfold calipers (Cambridge Scientific, Cambridge, MD) from the
subscapula and triceps (18). These measurements were used to estimate body fat percentage
using sex, race, and maturation level based formulas (21). Fat free mass (FFM) was
determined by subtracting predicted body fat percent (expressed as a decimal) from one and
multiplying by the subjects total body mass (kg).
Predicted aerobic power (pVO2max) in absolute units of mL/min was estimated from a
submaximal cycle ergometer test using the methods of McMurray et al. (17). The test
consisted of three, 3-min stages, each progressing in exertion level by 0.5 ± 1.0 W/kg body
mass. Estimated VO2max was predicted from the heart rate responses at each of the three
levels (power outputs), in comparison with the known oxygen uptake at each power output,
accounting for resting metabolic rate. This method has been shown to produce correlations
as high as r = .80 (SE = 4 mL/kg/min; 17) with measured VO2max. The cycle ergometers
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used in testing were calibrated BodyGuard (model 990), Tunturi magnetic-braked Tunuri Oy
Ltd., (Turku, Finland), or Monarch (model 818; Monark, Varberg, Sweden) cycle
ergometers. Predicted VO2max (mL/min) was divided by FFM giving the metric of mL of O2
per kilogram of fat free mass per min (mL/kgFFM/min) or VO2FFM. Predicted VO2max was
also computed in terms of mL of oxygen per kilogram body mass (mL/kg/min) or VO2kg.
Group Determination
Weight status was determined based upon the Centers for Disease Control and Prevention
(CDC) growth charts from the year 2000 which define normal, over-weight and obese in
children and adolescents (4). BMI was used for classification because no method for
classification has been developed for skinfolds. Normal weight was defined as <85th and
>fifth BMI percentile for age and sex. Obese was defined as >95th BMI percentile for age
and sex. Fitness was determined based upon predicted VO2FFM. VO2FFM was chosen to
reduce the influence of fatness which is confounded in the unit of VO2kg. Fitness cut-points
were developed (unpublished data) based on data from CHIC cohorts I, II, and III, collected
from 1992 to 2005, representing 3235 adolescents from age 8–12. Subjects that were in the
66th percentile or above for VO2FFM were included in the high fitness group; those with
VO2FFM less than the 33rd percentile were included in the low fitness group. VO2FFM
cutoffs by age and sex previously published elsewhere (12); refer to Table 1 for summary.
All subjects in the original study fitting both the obesity and high fitness criteria with
complete data were included in the OH group. This decision was made because of the small
number of youth that met the criteria. Of the original 1486 subjects, 44 in Tanner Stages 1–3
met the criteria of being obese and highly fit, but only 31 of these had complete data and
blood samples. Selection into the NH, NL, or OL group was done matching sex and pubertal
status to the OH group after having met the individual group criteria for weight and fitness
status.
Blood Analysis
Subjects were called the day before blood draws and reminded to not eat anything and drink
only water before their blood was drawn. Upon arrival subjects confirmed their overnight
fast and then a blood sample was obtained from the antecubital space. The blood samples
were centrifuged, separated into individual mircocentrifuge tubes with ~0.5 ml sample per
tube, then placed on dry ice to be transported to our storage facility, where they were
processed and then kept at −80 °C until later analysis.
All blood analysis was completed on stored samples, using commercially available assay
kits. Serum IL-6 values were determined using ELISA technique (Invitrogen, Camirillo, CA,
USA). The intra-assay coefficient of variation (CV) for IL-6 was 7.4%; with an interassay
CV of 9.9%. Invitrogen reports a sensitivity of <0.09 pg/mL. Tumor necrosis factor α (TNF-
α) values were also measured using an ELISA technique (Thermo Scientific, Rockford, IL,
USA).
The sensitivity of the TNF- α assay is <1 pg/mL. The intra-assay CV for TNF-α was 4.1%;
with an interassay CV of 11.2%.
Statistical Analysis
Means and SEM were computed for all variables by group (NH, NL, OH, and OL). To
determine if differences existed between the groups 2 × 2 analysis of variance (ANOVA)
was conducted separately for IL-6 and TNF- α, with pVO2max units and obesity categories
as the main effects. When a significant interaction effect was in ANOVA (p < .05), a Tukey
post hoc test was applied to determine which groups were different. To further explore any
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interrelationships, Spearman correlations controlling for differences in body fat were
performed between TNF-α, IL-6, and the two metrics of fitness (VO2FFM and VO2kg).
Spearman correlations were used because of the polarity of data produced by the group
selection; thus the data were not normally distributed. The alpha level was set at p < .05. All
statistical analysis was computed using SAS version 9.1 (Cary, NC).
Results
Forty four subjects were initially found to have both high fitness and obesity characteristics.
Of the 44, only 31 had complete data. There were no major VO2max or BMI differences
between the 13 OH subjects with incomplete data and the 31 with complete data. After
matching each group had 13 females and 18 males and groups did not differ by age (~10.1 ±
0.8 y) or Tanner stage (~2.3 ± 0.7). Complete group characteristics have been previously
published (12) and summarized in Table 2.
Results for IL-6 and TNF-α can be found in Figures 1 and 2, respectively. A significant
interaction effect was found between the groups for IL-6 (p < .05). The follow-up Tukey
determined that IL-6 levels in the OL group were significantly elevated compared with the
OH and NH (p < .05) groups. In addition, the NL groups IL-6 levels were significantly
elevated compared with the NH group (p < .05). No statistically significant interaction
effects were noted for TNF-α (p = .057). However, since there was a trend (p = .057), a
Tukey test was completed for exploratory purposes and a trend was found between the OL
and NH groups differences (p = .058; Figure 2).
The Spearman correlations used to further explore relationships between IL-6 and both units
of pVO2max were significant and similar: VO2FFM = −0.356 & VO2kg = −0.361 (p = .0001
for each). No significant relationships were found between either fitness metric or TNF-α:
VO2FFM = −0.138 (p = .126) & VO2kg = −0.145 (p = .109).
Discussion
This study compared markers of inflammation between normal weight youth of high or low
aerobic fitness to obese youth of high or low fitness. The findings show for the first time that
higher levels of VO2max are associated with lower levels of IL-6, independent of obesity.
Concomitantly, TNF-α did not significantly differ between the groups; however, a trend
toward lower values in the NH compared with the OL group (p = .057) was observed and
the Spearman correlations were in the right direction (inverse association with VO2max),
suggesting a potential relationship between fitness and obesity on the one hand and TNF-α
on the other.
The relationship between obesity (BMI or skinfolds) and inflammation has been well
established (7,13,23); however, the contribution of VO2max on the obesity related
inflammation is unclear (11). The findings of this investigation suggest IL-6 is more related
to VO2max than fatness, whereas the results of Halle et al. (11) suggest that TNF-α is more
related to fatness than VO2max. One possible explanation for the discrepancy could be the
polarized pVO2max criteria and BMI% used for group determination. Halle et al. (11) split
their subjects into two groups with normal weight being defined as a BMI < 22.5 kg/m2 and
obesity defined as BMI > 22.5 kg/m2. Based on the age and sex of the Halle subjects, the
BMI percentile for inclusion in their obese group would have been between the 76th and
95th percentile; thus some subjects in their “obese” group were not obese based on the CDC
definition of obesity. Including nonobese subjects in an “obese” group is confounding
because alterations to resting hormonal levels that influence inflammation occur around 30%
body fat (5) or the 85th BMI percentile (6). Further, Halle et al. (11) defined high-fit
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adolescents as having a maximal MET capacity ≥ 5 METs and low-fit adolescents have a
maximal MET capacity < 5 METs. Possessing a maximal MET capacity of even 6 has been
considered very low-fit (16). When estimating our data, low-fit subjects had an average
maximal MET capacity of 8.5 in the normal weight and 6.5 for the obese weight groups.
Therefore, it is likely that some of subjects in the Halle study considered “high-fit” were not
actually high-fit. Subject inclusion criteria used by Halle et al. could have led to some
spurious findings which likely do not exist in the current study due to the novel VO2max and
BMI percentile criteria used for group determination.
In the present investigation IL-6 was elevated in the NL group, but not in the OH group,
which further suggests that elevated VO2max can result in lower IL-6 levels, independent of
obesity. This could be related to the fact that IL-6 has both pro and anti-inflammatory
characteristics. During exercise muscle has been found to be a major producer of IL-6,
possibly to reduce inflammation or maintain blood glucose levels (9). Therefore, our
conclusion that IL-6 levels are more associated with fitness than fatness would seem
appropriate.
In the present investigation, the trend for higher TNF-α levels in the NH compared with the
OL group (p = .057) may help explain some of the elevation in IL-6, since TNF-α is known
to stimulate IL-6 through autocrine/paracrine mechanisms (8,20,22). However, our finding
that TNF-α was not significantly elevated, despite increased IL-6 is supported by the
findings of Russell et al. (20). Russell et al. (20) found TNF-α receptors to be elevated in
obese adolescent girls, which would allow TNF-α to bind to its receptor more easily and
have a greater effect (such as IL-6 stimulation) without a need for increased circulating
TNF-α concentration. Furthermore, TNF-α has been shown to act via autocrine/paracrine
mechanisms and increased TNF-α receptors, specifically TNF receptor 2 (1) which would
help promote the increase in IL-6 with only slightly higher levels of TNF-α in the OL group.
However, difference in TNF-α of approximately 0.5 pg/mL may not be physiologically
significant, but the potential increase in TNF-α receptors found in many tissues including
adipose tissue (15), may be what permitted the increased IL-6 levels in the present
investigation. Without the measurement of TNF-α receptor levels this explanation is only
speculation.
Predicted VO2max and body fat percentage were estimated which is a limitation of the
present investigation. Estimations were used because data collection occurred in schools
with issues of 1) limited space for metabolic equipment and 2) transportation of the
necessary metabolic equipment. However, our method for predicting VO2max was strong
with a correlation of 0.80 with measured VO2max and a standard error of 4 mL/kg/min (17).
In addition using the polarized groups should have eliminated some of the ambiguity
between groups. Skinfolds were measured in triplicate by trained staff using NHANES
procedures (18). The staff were trained by the same individual (RGM) and met strict
certification and quality control criteria. Thus, we do not feel these limitations affect our
findings. Finally, FFM is not a direct measure of muscle mass. Using FFM theoretically
eliminates fat mass and focuses more on metabolically active tissue which may better reflect
the capacity of the muscle although our results at present do not suggest using VO2FFM
versus VO2kg matters.
The present study found that a higher VO2max, expressed in either units of FFM or total
body mass, was associated with a lower level of IL-6. In addition, there was a trend for
TNF-α to be inversely related to both obesity and VO2max (expressed in either units (FFM
or mL/kg/min). Based on these results, the association between VO2max and IL-6 appears
independent of fatness; thus, perhaps IL-6 in youth is derived mainly from muscle tissue.
The trends in TNF-α may be a function of age or early puberty, perhaps the subjects were
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too young to develop an adult proinflammatory profile. Future investigations should
examine the source of IL-6 in a longitudinal study of children, including the period in
development when adolescents begin to demonstrate adult-like inflammatory profiles, and
the degree to which obesity and fitness influence autocrine/paracine action of TNF-α and
TNF-α receptors to determine whether these are influencing IL-6. Our findings also suggest
that when studying the relationship between inflammation and VO2max either unit of
expression (mL/kg/min or mL/kgFFM/min) may be appropriate. However, this may be an
artifact of the polar nature of our groups. Future studies including subjects considered
overweight should be done to investigate this relationship further.
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Mean (± SEM) resting IL-6 level of the normal weight high-fit (NH), normal weight low-fit
(NL), obese high-fit (OH), and obese low-fit (OL) groups. *p < .05 from NH and OH #p < .
05 from NH only
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Mean (± SEM) resting TNF- α level of the normal weight high-fit (NH), normal weight low-
fit (NL), obese high-fit (OH), and obese low-fit (OL) groups.
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Table 1
The 33rd% (low-fit) and 66th% (high-fit) cut-points of the presented by gender and age
Gender Age Fitness 33rd% (mL/kgFFM/min) Fitness 66th% (mL/kgFFM/min)
Male 8 51.8 59.3
Female 8 49.9 58.7
Male 9 52.4 59.8
Female 9 49.8 57.1
Male 10 49.2 57.8
Female 10 46.0 53.8
Male 11 47.8 55.7
Female 11 43.4 50.4
Male 12 47.1 53.2
Female 12 45.5 52.0
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Table 2
Mean ± SD of anthropometric and fitness variables presented by group
Normal High Fitness Normal Low Fitness Obese High Fitness Obese Low Fitness
BMI (kg/m2) 17.4 ± 5.7†‡ 17.6 ± 1.7†‡ 27.7 ± 4.9*# 27.7 ± 3.4*#
BMI percentile 53.2 ± 20.8†‡ 56.8 ± 24.0†‡ 97.8 ± 1.5*# 98.1 ± 1.2*#
Fat percentage 17.4 ± 5.7†‡ 16.0 ± 6.6†‡ 36.7 ± 11.0*# 32.2 ± 7.3*#
Fat Free Mass (kg) 27.9 ± 4.1†‡ 30.8 ± 5.4†‡ 37.1 ± 7.4*# 40.9 ± 6.0*#
VO2FFM 62.1 ± 8.1‡# 35.4 ± 6.6†* 64.8 ± 10.3‡# 35.1 ± 6.6†*
VO2kg 51.3 ± 7.5#†‡ 29.8 ± 6.4*†‡ 40.8 ± 9.0*#‡ 23.9 ± 5.6*#†
*
p < 0.05 from NH,
#
p < 0.05 from NL,
†
p < 0.05 from OH,
‡
p < 0.05 from O
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